Fewer Medicare Advantage Plans Have $0 Premiums in 2015

Prior authorizations create substantial administrative and financial burdens on physicians and patients and can disrupt the continuity of care.

On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.

The researchers emphasized the need for ongoing research and advocacy to further address drug affordability.

The annual wellness visit is beneficial for patients, providers, and payers with an emphasis on preventive care for early intervention.

Posters presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference show that therapeutic advances in treating spinal muscular atrophy (SMA) are not uniformly making it into the hands of patients who could benefit.

Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.